Approaches for the discovery of cinnamic acid derivatives with anticancer potential
- 6 August 2024
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 19 (10) , 1281-1291
Abstract
Cinnamic acid is a privileged scaffold for the design of biologically active compounds with putative anticancer potential, following different synthetic methodologies and procedures. Since there is a need for the production of potent anticancer, cinnamate moiety can significantly contribute in the design of new and more active anticancer agents. In this review, the authors provide a review on the synthetic approaches for the discovery of cinnamic acid derivatives with anticancer potential. Results from molecular simulations, hybridization, and chemical derivatization along with biological experiments in vitro and structural activity relationships are given, described, and discussed by the authors. Information for the mechanism of action is taken from original literature sources. The authors suggest that (i) numerous areas of biology-pharmacology need to be considered: selectivity, in vivo studies, toxicity and drug-likeness, the mechanism of action in animals and humans, development of more efficient assays for various cancer types; (ii) hybridization techniques outbalance in the discovery and production of compounds with higher activity and greater selectivity; (iii) repositioning offers new anticancer cinnamic agents.Keywords
This publication has 94 references indexed in Scilit:
- Molecular mechanism of ferulic acid and its derivatives in tumor progressionPharmacological Reports, 2023
- Cinnamic acid hybrids as anticancer agents: A mini‐reviewArchiv der Pharmazie, 2022
- Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathwayTumor Biology, 2013
- Design, Synthesis and Biological Evaluation of Caffeic Acid Amides as Selective MMP‐2 and MMP‐9 InhibitorsDrug Development Research, 2012
- Design, Synthesis, and Preliminary Evaluation of Substituted Cinnamic Acid Esters as Selective Matrix Metalloproteinase InhibitorsDrug Development Research, 2012
- Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cellsMedical Oncology, 2009
- The beta‐carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cellsPhytotherapy Research, 2009
- Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexesCancer Chemotherapy and Pharmacology, 2000
- Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasisCancer and Metastasis Reviews, 1995
- Keynote address: Hypoxic cell radiosensitizers: Where next?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989